ERK1/2 pathway mediates epithelial-mesenchymal transition by cross-interacting with TGFβ/Smad and Jagged/Notch signaling pathways in lens epithelial cells

Chen,Xiaoyun; Ye,Shaobi; Xiao,Wei; Wang,Wencong; Luo,Lixia; Liu,Yizhi

doi:10.3892/ijmm.2014.1723

ERK1/2 pathway mediates epithelial-mesenchymal transition by cross-interacting with TGFβ/Smad and Jagged/Notch signaling pathways in lens epithelial cells

Authors:
- Xiaoyun Chen
- Shaobi Ye
- Wei Xiao
- Wencong Wang
- Lixia Luo
- Yizhi Liu
View Affiliations

Affiliations: State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat‑sen University, Guangzhou, Guangdong 510060, P.R. China
Published online on: April 4, 2014 https://doi.org/10.3892/ijmm.2014.1723
Pages: 1664-1670

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Epithelial-mesenchymal transition (EMT) of lens epithelial cells (LECs) is the major pathological mechanism in anterior subcapsular cataract (ASC) and posterior capsule opacification (PCO), which are important causes of visual impairment. Extracellular signal-regulated kinase (ERK)1/2 pathway has been reported to play a major role in carcinogenesis, cancer metastasis and various fibrotic diseases. We hypothesized that ERK1/2 signaling can cross-interact with canonical transforming growth factor β (TGFβ)/Smad signaling and the Notch pathway, which subsequently contributes to LECs EMT. In this study, we demonstrated that ERK1/2 signaling was activated in TGFβ2‑induced EMT in human LECs, whereas the blockade of TGFβ2/Smad2/3 signaling with SB431542 did not inhibit the activation of ERK1/2 induced by TGFβ2. In addition, inactivation of ERK1/2 signaling with a specific MEK/ERK1/2 inhibitor, U0126, completely prevented the TGFβ2-induced upregulation of α-SMA, collagen type I, collagen type IV and fibronectin. We also demonstrated that inactivation of ERK1/2 signaling inhibited canonical TGFβ/Smad signaling, as well as the Jagged/Notch pathway. By contrast, blockade of the Notch pathway by DAPT inhibited the TGFβ2‑induced activation of ERK1/2 pathway in LECs. Thus, results of this study provide evidence for the complex interplay between ERK1/2, TGFβ/Smad, and Jagged/Notch signaling pathways in the regulation of EMT in LECs. Inhibition of the ERK1/2 pathway may therefore have therapeutic value in the prevention and treatment of ASC and PCO.

View Figures

View References

1	McCarty CA and Taylor HR: Recent developments in vision research: light damage in cataract. Invest Ophthalmol Vis Sci. 37:1720–1723. 1996.PubMed/NCBI
2	Nathu Z, Dwivedi DJ, Reddan JR, Sheardown H, Margetts PJ and West-Mays JA: Temporal changes in MMP mRNA expression in the lens epithelium during anterior subcapsular cataract formation. Exp Eye Res. 88:323–330. 2009. View Article : Google Scholar : PubMed/NCBI
3	Shin EH, Basson MA, Robinson ML, McAvoy JW and Lovicu FJ: Sprouty is a negative regulator of transforming growth factor β-induced epithelial-to-mesenchymal transition and cataract. Mol Med. 18:861–873. 2012.PubMed/NCBI
4	Apple DJ, Solomon KD, Tetz MR, et al: Posterior capsule opacification. Surv Ophthalmol. 37:73–116. 1992. View Article : Google Scholar
5	Hodge WG: Posterior capsule opacification after cataract surgery. Ophthalmology. 105:943–944. 1998. View Article : Google Scholar : PubMed/NCBI
6	Srinivasan Y, Lovicu FJ and Overbeek PA: Lens-specific expression of transforming growth factor beta1 in transgenic mice causes anterior subcapsular cataracts. J Clin Invest. 101:625–634. 1998. View Article : Google Scholar : PubMed/NCBI
7	de Iongh RU, Wederell E, Lovicu FJ and McAvoy JW: Transforming growth factor-beta-induced epithelial-mesenchymal transition in the lens: a model for cataract formation. Cells Tissues Organs. 179:43–55. 2005.PubMed/NCBI
8	Wallentin N, Wickström K and Lundberg C: Effect of cataract surgery on aqueous TGF-beta and lens epithelial cell proliferation. Invest Ophthalmol Vis Sci. 39:1410–1418. 1998.PubMed/NCBI
9	Meacock WR, Spalton DJ and Stanford MR: Role of cytokines in the pathogenesis of posterior capsule opacification. Br J Ophthalmol. 84:332–336. 2000. View Article : Google Scholar : PubMed/NCBI
10	Awasthi N, Guo S and Wagner BJ: Posterior capsular opacification: a problem reduced but not yet eradicated. Arch Ophthalmol. 127:555–562. 2009. View Article : Google Scholar : PubMed/NCBI
11	Allen JB, Davidson MG, Nasisse MP, Fleisher LN and McGahan MC: The lens influences aqueous humor levels of transforming growth factor-beta 2. Graefes Arch Clin Exp Ophthalmol. 236:305–311. 1998. View Article : Google Scholar : PubMed/NCBI
12	Eldred JA, Dawes LJ and Wormstone IM: The lens as a model for fibrotic disease. Philos Trans R Soc Lond B Biol Sci. 366:1301–1319. 2011. View Article : Google Scholar : PubMed/NCBI
13	Akhurst RJ and Hata A: Targeting the TGFβ signalling pathway in disease. Nat Rev Drug Discov. 11:790–811. 2012.
14	Li J, Tang X and Chen X: Comparative effects of TGF-β2/Smad2 and TGF-β2/Smad3 signaling pathways on proliferation, migration, and extracellular matrix production in a human lens cell line. Exp Eye Res. 92:173–179. 2011.
15	Dawes LJ, Sleeman MA, Anderson IK, Reddan JR and Wormstone IM: TGFbeta/Smad4-dependent and -independent regulation of human lens epithelial cells. Invest Ophthalmol Vis Sci. 50:5318–5327. 2009. View Article : Google Scholar : PubMed/NCBI
16	Chung EJ, Chun JN, Jung SA, Cho JW and Lee JH: TGF-β-stimulated aberrant expression of class III β-tubulin via the ERK signaling pathway in cultured retinal pigment epithelial cells. Biochem Biophys Res Commun. 415:367–372. 2011.
17	Chen XF, Zhang HJ, Wang HB, et al: Transforming growth factor-β1 induces epithelial-to-mesenchymal transition in human lung cancer cells via PI3K/Akt and MEK/Erk1/2 signaling pathways. Mol Biol Rep. 39:3549–3556. 2012.
18	Aomatsu K, Arao T, Sugioka K, et al: TGF-β induces sustained upregulation of SNAI1 and SNAI2 through Smad and non-Smad pathways in a human corneal epithelial cell line. Invest Ophthalmol Vis Sci. 52:2437–2443. 2011.
19	Choi J, Park SY and Joo CK: Transforming growth factor-beta1 represses E-cadherin production via slug expression in lens epithelial cells. Invest Ophthalmol Vis Sci. 48:2708–2718. 2007. View Article : Google Scholar : PubMed/NCBI
20	Xie L, Law BK, Chytil AM, Brown KA, Aakre ME and Moses HL: Activation of the Erk pathway is required for TGF-beta1-induced EMT in vitro. Neoplasia. 6:603–610. 2004. View Article : Google Scholar : PubMed/NCBI
21	Wang Z, Li Y, Kong D and Sarkar FH: The role of Notch signaling pathway in epithelial-mesenchymal transition (EMT) during development and tumor aggressiveness. Curr Drug Targets. 11:745–751. 2010. View Article : Google Scholar : PubMed/NCBI
22	Neuzillet C, Tijeras-Raballand A, de Mestier L, Cros J, Faivre S and Raymond E: MEK in cancer and cancer therapy. Pharmacol Ther. 141:160–171. 2013. View Article : Google Scholar
23	Tanahashi T, Osada S, Yamada A, et al: Extracellular signal-regulated kinase and Akt activation play a critical role in the process of hepatocyte growth factor-induced epithelial-mesenchymal transition. Int J Oncol. 42:556–564. 2013.
24	Pacheco-Domínguez RL, Palma-Nicolas JP, López E and López-Colomé AM: The activation of MEK-ERK1/2 by glutamate receptor-stimulation is involved in the regulation of RPE proliferation and morphologic transformation. Exp Eye Res. 86:207–219. 2008.PubMed/NCBI
25	Zhang YE: Non-Smad pathways in TGF-beta signaling. Cell Res. 19:128–139. 2009. View Article : Google Scholar : PubMed/NCBI
26	Leask A: Targeting the jagged/notch pathway: a new treatment for fibrosis? J Cell Commun Signal. 4:197–198. 2010. View Article : Google Scholar : PubMed/NCBI